Machine Learning Approaches in Structural Virology: Predicting Viral Protein Dynamics

Introduction

The prediction of viral protein structures and their dynamic conformational landscapes has become a cornerstone of modern computational virology. Machine learning (ML) models, particularly deep learning architectures, have revolutionized the ability to infer three-dimensional (3D) protein folds from primary amino acid sequences, to simulate conformational transitions, and to forecast receptor binding interfaces [1, 2]. These advances are critical for understanding host tropism, zoonotic spillover potential, and antigenic evolution in veterinary pathogens [3, 4]. The integration of ML with molecular dynamics (MD) simulations and free energy perturbation methods enables a multiscale approach to viral glycoprotein dynamics, as reviewed in the companion article Structural Virology and Molecular Dynamics: Predicting Viral Protein Conformations for Antiviral Design [5].

This review provides an exhaustive technical examination of how ML algorithms are applied to predict viral protein dynamics, focusing on receptor binding, conformational changes, and the implications for vaccine design in veterinary medicine. The discussion is tightly constrained to non-human pathogens and comparative host-range studies.

Machine Learning Architectures for Viral Protein Structure Prediction

Deep Learning Models for Static Structure Prediction

The most prominent breakthrough in structural biology has been the development of end-to-end deep learning models such as AlphaFold and its successors. These models leverage co-evolutionary information from multiple sequence alignments (MSAs) and a novel attention-based architecture (Evoformer) to produce highly accurate 3D coordinates [1]. In the context of veterinary virology, AlphaFold has been applied to predict the structures of envelope glycoproteins from avian influenza, porcine reproductive and respiratory syndrome virus (PRRSV), and bat coronaviruses, as detailed in the article AlphaFold and Beyond: Deep Learning for Protein Structure Prediction in Veterinary Virology [1]. The performance of such models is rigorously benchmarked in community-wide experiments such as CASP (Critical Assessment of Structure Prediction), which has revealed persistent bottlenecks in modeling flexible loops and glycoproteins with extensive glycan shielding [1].

Protein language models (pLMs), which are transformers pre-trained on large corpora of protein sequences, have emerged as powerful alternatives to MSA-based approaches. These models generate embeddings that encode structural and functional information, enabling zero-shot prediction of mutational effects [6, 7]. For example, pLMs have been used to predict drug resistance mutations in HIV (a lentivirus) and to design S1 subunits of the SARS-CoV-2 spike protein [6, 7]. In a veterinary setting, similar embeddings can be applied to predict escape mutations in influenza A hemagglutinin and to forecast host tropism shifts in avian coronaviruses [2, 8].

Graph Neural Networks and Protein-Protein Interaction Networks

Viral protein dynamics are inherently mediated by protein-protein interactions (PPIs). Graph neural networks (GNNs) operate on molecular graphs where nodes represent residues and edges represent spatial proximities or contacts. GNNs have been employed to model dynamic PPI networks and to predict complex formation between viral glycoproteins and host receptors [9, 10]. For instance, graph-based methods can predict the binding affinity of influenza hemagglutinin for avian versus mammalian sialic acid receptors, a critical determinant of host range [9]. Furthermore, hypergraph theories extend GNNs by representing multi-body interactions, which are essential for modeling the cooperative conformational changes during viral fusion [9].

Supervised learning approaches using random forests and gradient boosting have also been applied to predict Ebola virus-human PPIs, achieving high accuracy by integrating sequence-derived features and structural descriptors [11]. Similarly, ML models trained on experimentally validated coronavirus-host PPIs have identified novel interactors and validated them using independent computational methods [12].

Integration with Cryo-Electron Microscopy

Cryo-electron microscopy (cryo-EM) provides near-atomic resolution maps of viral protein complexes. Unsupervised classification of cryo-EM reconstructions of influenza surface spikes using head-to-stem width ratios permits automated sorting of conformational states [13]. Deep learning models have also been developed for 3D localization of retrovirus assembly sites within cellular environments, segmenting structured background noise from viral particles [14]. These ML-enhanced cryo-EM workflows accelerate the determination of dynamic ensembles for vaccine design.

The following table summarizes key ML architectures and their applications in structural virology.

Predicting Conformational Dynamics and Receptor Binding

Conformational Sampling and Transition Pathways

Viral glycoproteins undergo large-scale conformational rearrangements during cell entry, such as the pre-fusion to post-fusion transition in class I fusion proteins. MD simulations can map these transitions, but they are computationally expensive. ML models can accelerate sampling by learning the free energy landscape from short simulations and predicting low-energy pathways [17, 18]. For instance, deep learning combined with dynamic residue network analysis has identified mutation cold and hot spots in the SARS-CoV-2 main protease (Mpro), revealing residues that modulate active site flexibility [18]. Similar analyses applied to the avian H5N1 neuraminidase have guided repurposing of nucleoside analogs [3].

Generative models, including variational autoencoders, can produce novel conformations of viral proteins consistent with the learned energy landscape. A synergistic generative-ranking framework has been developed for designing therapeutic single-domain antibodies (nanobodies) that bind to spike protein epitopes with high affinity, a process that involves scoring generated structures with an ML-based binding predictor [19, 20]. The same principle can be applied to predict how mutations in receptor-binding domains (RBDs) alter conformational equilibrium and thus impact host range [21].

Receptor Binding Affinity Prediction

Quantifying the binding affinity between viral glycoproteins and host receptors is essential for assessing zoonotic risk. ML models trained on mutagenesis data, such as deep mutational scanning (DMS) libraries, can predict how sequence changes in the spike RBD affect binding to orthologous receptors (e.g., ACE2 from different bat or avian species) [21, 22]. The article Spike Protein Mutational Landscapes and ACE2 Binding Affinity Prediction Using Machine Learning provides a comprehensive discussion of this topic.

Random forest regressors and neural networks using features derived from Rosetta energy calculations (e.g., electrostatic complementarity, van der Waals clashes) have achieved strong predictive performance for influenza hemagglutinin-receptor binding [23]. Attention-based interpretability methods, such as those used in the HIV drug resistance benchmark, allow inference of which residues most strongly influence binding predictions [6].

Integrating Structural Variants

Structural variants (SVs) in viral genomes, such as insertions, deletions, and duplications, can dramatically alter protein dynamics. A dual-reference ML approach (SVLearn) has been developed for cross-species genotyping of SVs, enabling the detection of large-scale genomic changes that affect glycoprotein length or domain architecture [8]. This method has direct applications in monitoring avian influenza viruses for insertions in the hemagglutinin cleavage site that increase pathogenicity.

Applications in Vaccine Design and Antiviral Development

Epitope Prediction and Antibody Escape

ML-driven prediction of B-cell and T-cell epitopes from viral protein structures informs the design of subunit vaccines. Protein language model embeddings of viral glycoproteins have been used to predict antibody escape mutations and to guide the selection of vaccine strains that minimize antigenic drift [24, 25]. Structure-based deep learning models can also predict vaccine escape by modeling the steric and electrostatic consequences of mutations at antibody-binding interfaces, as described in the article Predicting Vaccine Escape Mutations Using Structure-Based Deep Learning.

For veterinary pathogens such as foot-and-mouth disease virus (FMDV) and bluetongue virus, ML-optimized epitope-engineering pipelines accelerate the development of broadly protective vaccines. The generative-ranking framework for nanobodies has also been applied to engineer mutation-resistant neutralizing antibodies against multiple coronavirus variants [24, 25].

Antiviral Drug Discovery

Virtual screening of small-molecule libraries against viral protein targets has been enhanced by ML scoring functions. For example, the MERS-Mpro Predictor uses a random forest model trained on biochemical assay data to rapidly flag potential main protease inhibitors [26]. An autoencoder-based approach for drug-virus association prediction (using low-dimensional embeddings of both compound and viral protein features) successfully identified approved drugs with activity against SARS-CoV-2 [15].

ML has also been applied to predict the antiviral activity of natural products, such as sea star steroids against SARS-CoV-2, and to design novel peptide inhibitors targeting the dengue virus envelope protein [16, 27]. In a veterinary context, similar pipelines are being used to screen compounds against the African swine fever virus (ASFV) p72 capsid protein and the PRRSV nsp4 protease. The companion article Structure-Guided Antiviral Design: Computational Modeling of Spike Protein Dynamics in Emerging Coronaviruses elaborates on these approaches.

Early Detection and Surveillance

ML frameworks have been developed for early detection of viral outbreaks from surveillance data, such as acute flaccid paralysis (AFP) data for polio in livestock, and for predicting highly pathogenic avian influenza (HPAI) epizootics using environmental and epidemiological features [28, 4]. These models integrate sequence-derived features (e.g., mutation signatures in the hemagglutinin gene) with spatial-temporal data to forecast disease emergence [28]. Predictive ML models for COVID-19 resurgences, while developed for human populations, can be adapted to veterinary systems by replacing host transmission parameters [29].

The following Mermaid diagram illustrates a typical ML workflow for predicting viral protein dynamics and its applications in vaccine design.

flowchart TD
    A[Viral Genome Sequence], > B[MSA Generation / Feature Extraction]
    B, > C{ML Architecture}
    C, > D[AlphaFold / Evoformer]
    C, > E[Protein Language Model]
    C, > F[Graph Neural Network]
    D, > G[Predicted 3D Structure]
    E, > H[Embeddings & Mutational Effects]
    F, > I[PPI & Binding Interface Scores]
    G, > J[MD Simulation & Conformational Sampling]
    H, > J
    I, > J
    J, > K[Free Energy Landscape / Transition Pathways]
    J, > L[Receptor Binding Affinity Prediction]
    L, > M[Host Range & Zoonotic Risk Assessment]
    K, > N[Antibody Escape & Vaccine Design]
    N, > O[Epitope Selection / Binder Design]
    M, > P[Surveillance & Outbreak Prediction]

Challenges and Future Directions

Despite remarkable progress, several bottlenecks remain. The conformational flexibility of viral glycoproteins, especially those with extensive glycosylation, challenges current structure prediction models [1, 13]. Glycan shield dynamics can obscure neutralizing antibody epitopes, and ML models must incorporate glycan composition and flexibility to accurately predict immune evasion, as discussed in Structural Bioinformatics of Viral Glycoprotein Glycan Shield Evasion.

Interpretability of deep learning models is another challenge. While attention-based mechanisms provide some insight, linking ML predictions to specific biophysical interactions requires careful validation [6, 30]. Surface plasmon resonance or biolayer interferometry experiments remain necessary to confirm predicted binding affinities.

Future directions include the development of foundation models pre-trained on large collections of viral protein sequences and structures, enabling few-shot learning for novel or emerging viruses [2, 7]. Integration of ML with structural mass spectrometry and cryo-electron tomography will allow modeling of viral proteins in their native membrane environment. Generative AI is also being explored for de novo design of antiviral peptides and fusion inhibitors [16, 24].

Conclusion

Machine learning has fundamentally transformed structural virology by enabling accurate prediction of viral protein structures, dynamics, and receptor interactions. From deep learning models like AlphaFold for static structure determination to GNNs for PPI networks and generative models for binder design, these computational tools provide a powerful framework for understanding host range, antigenic drift, and vaccine design in veterinary pathogens. Continued methodological advances, coupled with high-throughput experimental validation, will further refine our ability to predict and mitigate viral threats to animal health.

References

[1] Kryshtafovych A, Schwede T, Topf M, et al. Progress and Bottlenecks for Deep Learning in Computational Structure Biology: CASP Round XVI. Proteins. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41178755/

[2] Sinno A, Baghdadi R, Narch R, et al. Charting the virosphere: computational synergies of AI and bioinformatics in viral discovery and evolution. J Virol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41222234/

[3] Khan MY, Shah AU, Duraisamy N, et al. Repurposing of Some Nucleoside Analogs Targeting Some Key Proteins of the Avian H5N1 Clade 2.3.4.4b to Combat the Circulating HPAI in Birds: An In Silico Approach. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40733589/

[4] Ben Salem M, Andraud M, Bougeard S, et al. Investigating the role of environmental factors in the French highly pathogenic avian influenza epizootic in 2022-2023. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40586036/

[5] Berlin P, Mirzaei A, Steinbeck F, et al. Machine learning-guided multimodal profiling defines perturbed immune states at the time of cancer diagnosis. Brief Bioinform. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308424/

[6] Farquhar H. Protein language model embeddings improve HIV drug resistance prediction: a comprehensive benchmark with attention-based interpretability. Bioinformatics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42105210/

[7] Rancati S, Nicora G, Bergomi L, et al. SARITA: a large language model for generating the S1 subunit of the SARS-CoV-2 spike protein. Brief Bioinform. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40755284/

[8] Yang Q, Sun J, Wang X, et al. SVLearn: a dual-reference machine learning approach enables accurate cross-species genotyping of structural variants. Nat Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40069188/

[9] Chan KY, Yamaguchi T, Izumiya Y, et al. Graph and Hypergraph Theories Applied to Dynamic Protein-Protein Interaction Network Analysis, and Deep-Learning Frameworks for Protein Complex Network Prediction. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42278281/

[10] Degnan DJ, Strauch CW, Obiri MY, et al. Protein-Protein Interaction Networks Derived from Classical and Machine Learning-Based Natural Language Processing Tools. J Proteome Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39526844/

[11] Dey L, Chakraborty S. Supervised learning approaches for predicting Ebola-Human Protein-Protein interactions. Gene. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39828063/

[12] Li B, Li X, Tang X, et al. Prediction and Evaluation of Coronavirus and Human Protein-Protein Interactions Integrating Five Different Computational Methods. Proteins. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40231383/

[13] Benkarroum Y. Unsupervised classification of influenza virus surface spikes from cryo-EM reconstructions using head-to-stem width ratio. Virol J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41214782/

[14] Kohler J, Hur KH, Wray E, et al. 3D localization of retrovirus assembly in the presence of structured background with deep learning. Biophys J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40883991/

[15] Aruna AS, Remesh Babu KR, Deepthi K. Autoencoder-based drug-virus association prediction with reliable negative sample selection: A case study with COVID-19. Biophys Chem. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40096790/

[16] Duy HA, Srisongkram T. Deep Generative Models for the Discovery of Antiviral Peptides Targeting Dengue Virus: A Systematic Review. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40649934/

[17] Wang J, Xie J, Yu Y, et al. Enhancing the understandings on SARS-CoV-2 main protease (M(pro)) mutants from molecular dynamics and machine learning. Int J Biol Macromol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40220823/

[18] Barozi V, Chakraborty S, Govender S, et al. Revealing SARS-CoV-2 M(pro) mutation cold and hot spots: Dynamic residue network analysis meets machine learning. Comput Struct Biotechnol J. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39525081/

[19] Kong Y, Shi J, Wu F, et al. A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies. Cell Discov. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41162386/

[20] Ferraz MVF, Adan WCS, Lima TE, et al. Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning. PLoS Comput Biol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40257976/

[21] Netsey EK, Naandam SM, Asante Jnr J, et al. Structural and Functional Impacts of SARS-CoV-2 Spike Protein Mutations: Insights From Predictive Modeling and Analytics. JMIR Bioinform Biotechnol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359941/

[22] Chhibbar P, Guha Roy P, Harioudh MK, et al. Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks. Cell Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39504244/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[23] Khan WH, Khan N, Tembhre MK, et al. Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains. Mol Divers. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40085404/

[24] Kang Y, Jin K, Pan L. AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40319133/

[25] Zhu F, Rajan S, Hayes CF, et al. Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape. Sci Adv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40153503/

[26] Ouassaf M, Alhatlani BY. MERS-Mpro Predictor: A Machine Learning-Based Tool for Rapid Screening of Potential MERS-CoV Main Protease Inhibitors. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42123685/

[27] Abd El Hafez MSM, Maiyza AI, Hassan HA, et al. Analytical and machine learning approaches identify a sea star steroid with promising activity for COVID-19 therapeutic development. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41057530/

[28] Gemechu H, Biru G, Gebremeskel E, et al. Machine learning framework for early detection of polio outbreaks from acute flaccid paralysis surveillance data. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41806444/

[29] Ferreira RS, Colnago M, Casaca W. Predictive and interpretable machine learning for COVID-19 resurgences: the role of SARS-CoV-2 variants in the post-pandemic era. BMC Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41430647/

[30] Souza AS, Amorim VMF, Soares EP, et al. Antagonistic Trends Between Binding Affinity and Drug-Likeness in SARS-CoV-2 Mpro Inhibitors Revealed by Machine Learning. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40733553/

[31] Jagadish M, Mohanty SN. A Generative AI-Based Framework for COVID-19 Screening from Cough Audio Signals. J Vis Exp. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41911284/

[32] Scolari FL, Spinardi J, Silva MMDD, et al. Impact of long COVID phenotypes on quality of life following symptomatic omicron infection in Brazil: a machine learning analysis. BMC Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41204118/

[33] Wang K, Xu J, Li X, et al. Evolutionary selection of trimethoprim-resistant dfrA genes in lytic phages affects phage and host fitness during infection. Sci Adv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41004581/

[34] Kawamoto S, Morikawa Y, Yahagi N. Reducing invasive RSV diagnostic testing with machine learning: A retrospective validation study. J Infect Public Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40930007/

[35] Sinsulpsiri S, Nishii Y, Xu-Xu QF, et al. Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40011571/